Company Profiles: KC Green Holdings Co., Ltd

Company Profiles: KC Green Holdings Co., Ltd PDF Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :

Get Book Here

Book Description

Company Profiles: KC Green Holdings Co., Ltd

Company Profiles: KC Green Holdings Co., Ltd PDF Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :

Get Book Here

Book Description


Company Profiles: Green International Holdings Limited

Company Profiles: Green International Holdings Limited PDF Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :

Get Book Here

Book Description


Official Summary of Security Transactions and Holdings Reported to the Securities and Exchange Commission Under the Securities Exchange Act of 1934 and the Public Utility Holding Company Act of 1935

Official Summary of Security Transactions and Holdings Reported to the Securities and Exchange Commission Under the Securities Exchange Act of 1934 and the Public Utility Holding Company Act of 1935 PDF Author:
Publisher:
ISBN:
Category : Securities
Languages : en
Pages : 628

Get Book Here

Book Description


NUCYNTA ER Drug Profile, 2023

NUCYNTA ER Drug Profile, 2023 PDF Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899631
Category : Medical
Languages : en
Pages : 153

Get Book Here

Book Description

NUCYNTA ER Drug Profile, 2023

This report focuses on NUCYNTA ER and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources


NAMZARIC Drug Profile, 2023

NAMZARIC Drug Profile, 2023 PDF Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899704
Category : Medical
Languages : en
Pages : 114

Get Book Here

Book Description

NAMZARIC Drug Profile, 2023

This report focuses on NAMZARIC and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources


Philippine Business Profiles

Philippine Business Profiles PDF Author:
Publisher:
ISBN:
Category : Corporations
Languages : en
Pages : 478

Get Book Here

Book Description


Nelson's Directory of Investment Research

Nelson's Directory of Investment Research PDF Author:
Publisher:
ISBN:
Category : Corporations
Languages : en
Pages : 1336

Get Book Here

Book Description


Nelson Information's Directory of Investment Research

Nelson Information's Directory of Investment Research PDF Author:
Publisher:
ISBN:
Category : Corporations
Languages : en
Pages : 1336

Get Book Here

Book Description


Thomas Register of American Manufacturers

Thomas Register of American Manufacturers PDF Author:
Publisher:
ISBN:
Category : Manufactures
Languages : en
Pages : 1978

Get Book Here

Book Description
This basic source for identification of U.S. manufacturers is arranged by product in a large multi-volume set. Includes: Products & services, Company profiles and Catalog file.

Official Gazette of the United States Patent Office

Official Gazette of the United States Patent Office PDF Author: United States. Patent Office
Publisher:
ISBN:
Category : Patents
Languages : en
Pages : 746

Get Book Here

Book Description